1. A. Chmiel, S. Grudziński - Biotechnologia i chemia antybiotyków. PWN Warszawa 1998.
2. I. Chopra, M. Roberts - Tetracycline Antibiotics: Mode of action, Applications, Molecular Biology, and Epidemiology of Bacterial Resistance. Microbiology and Molecular Biology Revievs 2001; 65: 232-260.
3. J. Davies, G. D. Wright - Bacterial resistance to aminoglycoside antibiotics. Trends in Microbiology 1997; 5: 234-239.
4. S. Douthwite, W. S. Champney - Structures of ketolides and macrolides determine their mode of interaction with the ribosomal target site. Journal of Antimicrobial Chemotherapy 2001; 48: 1-8.
5. R. Hancock, D. Chapple - Peptide antibiotics. Antimicrobial Agents and Chemotherapy 1999; 43: 1317- 1323.
6. E. Jawetz, J. L. Melnick, E. A. Adelberg - Przegląd mikrobiologii lekarskiej. PZWL Warszawa 1991.
7. L. P. Kotra, J. Haddad, S. Mobashery - Aminoglycosides: Perspectives on Mechanisms of Action and Resistance and Strategies to Counter Resistance. Antimicrobial Agents and Chemotherapy 2000; 44: 3249- 3256.
8. B. Mickowska - Peptydy antybakteryjne - struktura i funkcja. Postępy Biologii Komórki 2001; 28: suplement 16: 245-259.
9. M. P. Mingeot-Leclercq, P. M. Tulkens - Aminoglycosides: Nephrotoxicity Antimicrobial Agents and Chemotherapy 1999; 43: 1003-1012.
10. J. N. Samaha-Kfoury, G. F. Araj - Recent developments in lactamases and extended spectrum lactamases. British Medical Journal 2003; 327: 1209-1213.
11. A. Zejc, M. Gorczyca (red.) - Chemia leków. PZWL Warszawa 1999.